AC
Adage Capital Management, L.P. cut its IRD stake below 5%
Adage Capital Management, L.P. reported owning 2.7% of Opus Genetics, Inc. (IRD) (2,254,996 shares) in a Schedule 13G filed Nov 12, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.